Showing results (131-140 of 1,142) with videos related to
Sort By:
Pageof 115
Hepatology (Baltimore, Md.)|October 6, 2023
Noninvasive assessment of hepatic decompensationMaja Thiele, Stine Johansen, Mads Israelsen, et al.Cells|May 14, 2020
Macrophage Activation Markers, CD163 and CD206, in Acute-on-Chronic Liver FailureMarlene Christina Nielsen, Rasmus Hvidbjerg Gantzel, Joan Clària, et al.International Journal of Molecular Sciences|September 3, 2020
Phosphodiesterases in the Liver as Potential Therapeutic Targets of Cirrhotic Portal HypertensionWolfgang Kreisel, Denise Schaffner, Adhara Lazaro, et al.Medizinische Klinik, Intensivmedizin Und Notfallmedizin|October 12, 2021
[Management of acutely decompensated liver cirrhosis in emergency and critical care medicine]Philipp Kasper, Frank Tacke, Guido MichelsCurrent Opinion in Gastroenterology|January 31, 2022
Macrophages in cholangiopathiesAlix Bruneau, Adrien Guillot, Frank TackeInflammation & Allergy Drug Targets|June 19, 2009
Monocytes and macrophages as cellular targets in liver fibrosisFelix Heymann, Christian Trautwein, Frank TackeClinical Reviews in Allergy & Immunology|July 5, 2008
Inflammatory pathways in liver homeostasis and liver injuryFrank Tacke, Tom Luedde, Christian TrautweinCellular Immunology|February 19, 2018
Dynamic plasticity of macrophage functions in diseased liverThomas Ritz, Oliver Krenkel, Frank TackeF1000Research|July 14, 2018
Recent advances in understanding liver fibrosis: bridging basic science and individualized treatment conceptsRalf Weiskirchen, Sabine Weiskirchen, Frank TackeDiabetes, Obesity & Metabolism|February 11, 2026
Providing holistic care for patients with metabolic dysfunction-associated steatotic liver disease/metabolic dysfunction-associated steatohepatitis: Key aspects of clinical assessment and how to develop individualised care plans for surveillance and interventionsLanlan Chen, Paul Horn, Frank TackePageof 115